tiprankstipranks
Xbrane Biopharma AB (SE:XBRANE)
:XBRANE
Sweden Market
Want to see SE:XBRANE full AI Analyst Report?

Xbrane Biopharma AB (XBRANE) Technical Analysis

10 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
1Bullish
0Neutral
12Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Xbrane Biopharma AB’s (XBRANE) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Xbrane Biopharma AB is a Buy.
Xbrane Biopharma AB’s (XBRANE) 20-Day exponential moving average is 10.41, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Sell.
Xbrane Biopharma AB’s (XBRANE) 50-Day exponential moving average is 10.33, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Sell.

Xbrane Biopharma AB (XBRANE) Pivot Points

Jul 31, 2026, 08:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xbrane Biopharma AB (XBRANE) Moving Averages

Jul 31, 2026, 08:07 PM
Period
Simple
Exponential
MA5
10.23Sell
10.20Sell
MA10
10.30Sell
10.29Sell
MA20
10.50Sell
10.41Sell
MA50
10.60Sell
10.33Sell
MA100
9.32Buy
10.67Sell
MA200
10.62Sell
14.08Sell
Xbrane Biopharma AB’s (XBRANE) 10-Day exponential moving average is 10.29, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Sell.
Xbrane Biopharma AB’s (XBRANE) 100-Day exponential moving average is 10.67, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Sell.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 50-day simple moving average is 10.60, creating a Sell signal.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 100-day simple moving average is 9.32, creating a Buy signal.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 200-day simple moving average is 10.62, creating a Sell signal.

Xbrane Biopharma AB (XBRANE) Technical Indicators

Jul 31, 2026, 08:07 PM
Name
Value
Implied Action
RSI (14)
46.12
Neutral
STOCH (9,6)
30.08
Neutral
STOCHRSI (14)
23.00
Neutral
MACD (12,26)
-0.08
Buy
ADX (14)
27.48
Neutral
Williams %R
-70.18
Buy
CCI (14)
-135.25
Buy
ATR (14)
0.59
-
Ultimate Oscillator
45.87
Neutral
ROC
-6.54
Sell
Xbrane Biopharma AB’s (XBRANE) Relative Strength Index (RSI) is 46.12, creating a Neutral signal.
Xbrane Biopharma AB’s (XBRANE) Trend Strength Indicator (ADX) is 27.48, creating a Neutral signal.
Xbrane Biopharma AB’s (XBRANE) Commodity Channel Index (CCI) is -135.25, creating a Buy signal.
Xbrane Biopharma AB’s (XBRANE) Price Rate of Change (ROC) is -6.54, creating a Sell signal.

FAQ

Is XBRANE a Buy, Hold, or Sell?
Based on XBRANE’s technical indicators, XBRANE is a Strong Sell.
    What is XBRANE’s RSI (14)?
    XBRANE’s RSI (14) is 46.12, which suggests XBRANE is a Neutral.
      What is XBRANE’s MACD?
      XBRANE’s MACD is -0.08, which suggests XBRANE is a Buy.
        What is XBRANE’s 5-day moving average?
        XBRANE’s 5-day moving average is 10.23, which suggests XBRANE is a Sell.
          What is XBRANE’s 20-day moving average?
          XBRANE 20-day moving average is 10.50, which suggests XBRANE is a Sell.
            What is XBRANE’s 50-day moving average?
            XBRANE’s 50-day moving average is 10.60, which suggests XBRANE is a Sell.
              What is XBRANE’s 200-day moving average?
              XBRANE’s 200-day moving average is 10.62, which suggests XBRANE is a Sell.
                What is XBRANE’s Williams % R (14)?
                XBRANE’s Williams % R (14) is -70.18, which suggests XBRANE is a Buy.
                  What is XBRANE’s CCI (14)?
                  XBRANE’s CCI (14) is -135.25, which suggests XBRANE is a Buy.
                    What is the share price of Xbrane Biopharma AB?